Table 1.
Embryos | DMSO | 5 μM | 25 μM | 50 μM | 75 μM | 100 μM | 125 μM | 150 μM |
---|---|---|---|---|---|---|---|---|
Sertraline | 0 | 0 | 1 | 4 | 4 | 4 | 4 | 4 |
Paroxetine | 0 | 0 | 1 | 3 | 4 | 4 | 4 | 4 |
Chlorpromazine | 0 | 0 | 0 | 1 | 3 | 4 | 4 | 4 |
L1 | DMSO | 5 μM | 25 μM | 50 μM | 75 μM | 100 μM | 125 μM | 150 μM |
Sertraline | 0 | 0 | 1 | 4 | 4 | 4 | 4 | 4 |
Paroxetine | 0 | 0 | 1 | 1 | 4 | 4 | 4 | 4 |
Chlorpromazine | 0 | 0 | 0 | 0 | 2 | 2 | 4 | 4 |
L3/L4 | DMSO | 5 μM | 25 μM | 50 μM | 75 μM | 100 μM | 125 μM | 150 μM |
Sertraline | 0 | 0 | 0 | 2 | 2 | 3 | 4 | 4 |
Paroxetine | 0 | 0 | 0 | 0 | 1 | 2 | 4 | 4 |
Chlorpromazine | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 |
Adults | DMSO | 5 μM | 25 μM | 50 μM | 75 μM | 100 μM | 125 μM | 150 μM |
Sertraline | 0 | 0 | 1 | 3 | 4 | 4 | 4 | 4 |
Paroxetine | 0 | 0 | 0 | 1 | 4 | 4 | 4 | 4 |
Chlorpromazine | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 4 |
All treatments were performed in duplicate wells, N = 50–100 worms/well, with each experiment repeated at least 3 times. Points were assigned for each scored effect based on the scoring descriptors below after 48 h of drug exposure and additive for each phenotype observed, with a maximum allowed total score of 4. Scoring descriptors were assigned when the entire test population exhibited the phenotype. Arrested = 1; Developmental delay = 1; Lethargic = 1; Paralyzed = 1; Toxic (>90% lethality) = 2; Dead = 4.